Gallstones on GLP-1 medicines: why the risk rises and how to protect yourself
AI Summary
Rapid weight loss and GLP-1 medicines can raise the risk of gallstones. Regular meals, a little healthy fat in meals, fiber-rich foods, enough water and a steady pace of weight loss help lower the risk. This article also covers the symptoms that mean you should see a doctor without waiting.
Losing weight quickly raises the risk of gallstones forming in the gallbladder. The official product information for GLP-1 medicines also lists gallbladder problems as a known risk. Regular meals, a little healthy fat in meals, fiber-rich foods, enough water and a steady pace of weight loss help lower the risk. Some symptoms mean you should see a doctor without waiting.
What does the gallbladder do?
The gallbladder stores bile, which the liver makes. When you eat, especially when a meal contains some fat, it contracts and empties bile into the intestine. If bile sits in the gallbladder for a long time, the cholesterol in it can settle out and form stones.
Why does the risk go up?
- Rapid weight loss: When weight comes off quickly, the liver releases more cholesterol into bile.
- Skipping meals: When your appetite drops, it becomes easy to skip meals. Without food, the gallbladder does not contract and bile sits inside it.
- Too little fat: Meals with no fat at all make the gallbladder empty less. In a small study of very-low-calorie diets, more than half of the participants on the diet with very little fat developed stones; none did on the diet with a little more fat.
- The medicine itself: In an analysis that pooled randomized trials, gallbladder and bile duct diseases were more common with GLP-1 medicines than with placebo or other medicines. The increase was clearer with use for weight loss and with longer use; the absolute risk stayed small.
Who is at higher risk?
Women, people over 40, people with a family history of gallstones, people who have had gallstones before, and people who lose weight very quickly.
How can you protect yourself?
- Don't skip meals. Even when your appetite is low, eat small meals at regular times through the day.
- Include a little healthy fat in your meals: olive oil, walnuts, hazelnuts, almonds or avocado, for example. Don't cut out fat completely.
- Eat more fiber: vegetables, fruit, beans, lentils and whole grains.
- Drink water regularly through the day. These medicines can cause constipation, nausea or vomiting; enough fluid matters for both your bowels and your kidneys. For most adults, about 1.5–2 liters (about 6–8 cups) a day from water and other drinks is enough; you need more in hot weather and on active days. If you have heart or kidney disease, ask your doctor how much to drink.
- Lose weight at a steady pace. About 0.5 to 1 kg (roughly 1 to 2 lb) a week is generally considered safer. If you are losing much faster than that, talk to your doctor.
- Stay active. Regular physical activity is associated with a lower risk of gallstones.
- If your risk is high, your doctor may suggest a preventive medicine; that decision belongs to your doctor.
Don't wait with these symptoms
If any of the following happens, see a doctor or go to the emergency department the same day, and say that you take a GLP-1 medicine:
- Pain in the upper right or upper middle part of your abdomen that lasts a few hours or keeps getting worse; it may spread to your right shoulder or back and often starts after a meal.
- Fever or chills.
- Yellowing of the eyes or skin, dark urine, pale stools.
- Severe abdominal pain that spreads to your back and does not go away, with vomiting; this can be a sign of pancreatitis (inflammation of the pancreas).
Questions to ask your doctor
- Is my risk of gallstones high? Do I need an ultrasound before I start?
- What should I do if I lose weight very quickly?
- Do I need a preventive medicine?
Sources
- FDA-approved prescribing information, Warnings, acute gallbladder disease: semaglutide · tirzepatide
- He L, et al. Association of Glucagon-Like Peptide-1 Receptor Agonist Use With Risk of Gallbladder and Biliary Diseases: A Systematic Review and Meta-analysis of Randomized Clinical Trials. JAMA Intern Med. 2022;182(5):513–519.
- Festi D, et al. Gallbladder motility and gallstone formation in obese patients following very low calorie diets. Use it (fat) to lose it (well). Int J Obes. 1998.
- NIDDK (US National Institutes of Health), gallstones: symptoms and causes · eating, diet and nutrition
- EFSA (European Food Safety Authority). Scientific Opinion on Dietary Reference Values for water. EFSA Journal. 2010;8(3):1459.
Related: GLP-1 medicines: frequently asked questions
Medical content review: Prof. Dr. Varlık Erol, Professor of General Surgery · Gila advisor. He reviewed the Turkish original; this English version is Gila's translation.
Last updated: November 1, 2026 · Editor: Sezen Soykut · support@gila.coach
This page is for information only and is not medical advice. Make decisions with your doctor.
Related Articles

Retatrutide vs Semaglutide: What the TRANSCEND-T2D-2 Head-to-Head Trial Is Built to Test
When a new medicine is set against one you already know, the first question is usually: is it better? For retatrutide, which is still investigational, and semaglutide, the honest starting point is the trial design itself. This page explains what the head-to-head study measures and what it cannot tell you.
Read more
Vitamin B12 and other nutrients on GLP-1 medication: what is known, and what is not
When the medication quiets your appetite, the plate gets smaller. For many people, that is the relief they were hoping for. It also raises a fair question: if you are eating less, are you still getting enough of the vitamins and minerals your body runs on?
Read more
What the Oura and UC San Diego Health GLP-1 Study Will Measure, and What Your Wearable Can Show You Now
If you started a GLP-1 medication and you already wear a ring or a watch, you have probably wondered whether all that sleep and heart rate data means anything for your journey. It is a fair question, and it is one researchers are now setting out to study. No results exist yet: the trial is not yet recruiting.
Read moreGila is coming to iPhone and Android
Your doses, meals, habits and food noise in one daily timeline. Join the waitlist and we’ll email you when it’s on your phone.
Join the waitlist